Navigation Links
Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution
Date:12/9/2009

SANTA MONICA, Calif. and WALTHAM, Mass., Dec. 10 /PRNewswire/ -- Reprints Desk, Inc., and QUOSA, Inc., today announced that Cubist Pharmaceuticals has become the first shared customer to activate integration between Reprints Desk's STM Document Delivery service with QUOSA's Virtual Library, which facilitates copyright-compliant article archiving and scientific literature re-use. The integrated solution features integration with Rightsphere, the rights advisory and management tool from Copyright Clearance Center (CCC), which already integrates independently with both Reprints Desk and QUOSA.

"The integration of QUOSA's powerful solution for archiving and sharing scientific journal articles with Reprints Desk's ultra-rapid document delivery service was a logical collaboration for delivering the efficiency and compliance benefits we've been seeking to enhance our eLiterature services," said A. Amyas Huston, Senior Manager of Medical Communications at Cubist. "With QUOSA already deployed and Reprints Desk delivery not requiring any platform fees or any IT information technology involvement from Cubist, the implementation within our workflow processes was fast and seamless."

Lexington MA-based Cubist Pharmaceuticals has been a QUOSA customer and a Reprints Desk customer since 2007. QUOSA serves a large and rapidly growing subscriber-base at leading pharmaceutical, biotechnology and other life-science companies, with solutions for efficiently managing and monitoring scientific literature. Reprints Desk earned the top ranking overall and in every category in the 2008 Document Delivery Best Practices and Vendor Scorecard by analyst and advisory firm Outsell, Inc., and scored a 97% customer satisfaction rating in Dun & Bradstreet's 2009 Open Ratings survey of existing Reprints Desk customers.

For more information about Reprints Desk and its STM Document Delivery service, visit the Reprints Desk website online at www.reprintsdesk.com. For additional information about QUOSA's solutions for efficiently managing and monitoring scientific literature and the QUOSA Virtual Library, visit www.quosa.com.

About QUOSA®

QUOSA Inc. is a specialist software company focused on literature management workflows and archives, which include full-text articles and patents. With a large and rapidly growing subscriber-base at leading pharmaceutical, biotechnology and other life-science companies, and in research and medical centers, QUOSA's applications are used to compress the time to insight and action across the key functions of the innovation enterprise. For more information about QUOSA, please visit the website at www.quosa.com.

About Reprints Desk®

Reprints Desk, Inc. (www.reprintsdesk.com) is a business software and information services company that simplifies how research-intensive companies and other organizations procure, manage and share journal articles and other copyright-protected content. The company's content workflow and compliance solutions help customers effectively use peer-reviewed literature in research, regulatory submissions, and product promotions. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc., and currently serves companies in life sciences, energy, aerospace, industrial products, consumer packaged goods, food and beverages, information technology, legal, and government. Reprints Desk is a Derycz Scientific company. For more information about Reprints Desk, contact Ian Palmer at +1 (707) 658-1931.


Public and Media Relations Contacts:
------------------------------------

Ian Palmer, Head of Marketing
Reprints Desk, Inc. | +1 707.658.1931
ipalmer@reprintsdesk.com

SOURCE Reprints Desk, Inc.


'/>"/>
SOURCE Reprints Desk, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lees Pharmaceuticals
2. BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors
3. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
4. Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
5. Rib-X Pharmaceuticals Expands License Agreement with Yale University on New Ribosome Technology
6. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
7. Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals Universal Flu Vaccine
8. Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference
9. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
10. Jazz Pharmaceuticals Appoints Kathryn Falberg as Chief Financial Officer
11. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amiras Lead DP2 Antagonist, AM211
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology:
(Date:4/28/2017)... LINCOLN, R.I. (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much ... Sleep Foundation (NSF), going just 19 hours without sleep can compromise motor reaction time, which ... Awareness Week, and Amica Insurance is sharing the following tips from the NSF to help ...
(Date:4/28/2017)... ... April 28, 2017 , ... Date aired: ... , “Computers are everywhere and they’re here to stay,” said Sharon Kleyne on ... and Your Health on Voice America sponsored by Nature’s Tears® EyeMist®. So she ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management Association (RBMA) ... 2017-2018. The annual board election process has been in place since the RBMA was ... C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):